tiprankstipranks
MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ:MIRA
US Market

MIRA Pharmaceuticals, Inc. (MIRA) Financial Statements

288 Followers

MIRA Pharmaceuticals, Inc. Financial Overview

MIRA Pharmaceuticals, Inc.'s market cap is currently $46.64M. The company's EPS TTM is $-0.483; its P/E ratio is -1.12; MIRA Pharmaceuticals, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -10.49M$ -8.02M$ -8.53M$ -7.05M$ -2.15M
EBITDA$ -10.49M$ -8.02M$ -8.53M$ 0.00$ 0.00
Net Income$ -10.44M$ -7.85M$ -11.98M$ -7.06M$ -2.18M
Balance Sheet
Cash & Short-Term Investments$ 6.35M$ 2.83M$ 4.60M$ 350.98K$ 2.81M
Total Assets$ 11.09M$ 2.92M$ 4.93M$ 858.07K$ 3.36M
Total Debt$ 0.00$ 0.00$ 5.06K$ 491.23K$ 293.06K
Net Debt$ -6.35M$ -2.83M$ -4.60M$ 140.25K$ -2.52M
Total Liabilities$ 702.07K$ 723.35K$ 558.10K$ 1.45M$ 1.09M
Stockholders' Equity$ 10.39M$ 2.20M$ 4.37M$ -596.23K$ 2.26M
Cash Flow
Free Cash Flow$ -4.66M$ -5.56M$ -4.53M$ -5.60M$ -1.38M
Operating Cash Flow$ -4.66M$ -5.56M$ -4.53M$ -5.60M$ -1.38M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 8.18M$ 3.79M$ 8.78M$ 3.15M$ 4.18M
Currency in USD

MIRA Pharmaceuticals, Inc. Earnings and Revenue History

MIRA Pharmaceuticals, Inc. Debt to Assets

MIRA Pharmaceuticals, Inc. Cash Flow

MIRA Pharmaceuticals, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.